blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1663174

EP1663174 - SINGLE UNIT PHARMACEUTICAL COMPOSITION COMPRISING A MIXTURE OF A FIBRATE AND A HOMOCYSTEINE REDUCING AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.06.2008
Database last updated on 03.10.2024
Most recent event   Tooltip26.09.2008Change - representativepublished on 29.10.2008  [2008/44]
Applicant(s)For all designated states
Galephar M/F
39, rue du Parc Industriel
6900 Marche-en-Famenne / BE
[2006/23]
Inventor(s)01 / VANDERBIST, Francis
Alsembergsesteenweg 1116
B-1650 Beersel / BE
02 / BAUDIER, Philippe
Rue Engeland 338
B-1180 Uccle / BE
03 / DEBOECK, Arthur
HCO2 Box 14885, Gurabo
Puerto Rico00778 / US
04 / SERENO, Antonio
Passiewyk 21
B-1820 Melsbroeck / BE
 [2006/23]
Representative(s)Vandeberg, Marie-Paule L.G., et al
Office Kirkpatrick
32, avenue Wolfers
1310 La Hulpe / BE
[N/P]
Former [2008/44]Vandeberg, Marie-Paule L.G., et al
Office Kirkpatrick 32, avenue Wolfers
1310 La Hulpe / BE
Former [2007/40]Vandeberg, Marie-Paule L.G., et al
Office Kirkpatrick S.A. 32, avenue Wolfers
1310 La Hulpe / BE
Former [2007/26](deleted)
Former [2006/23]Powis de Tenbossche, Roland, et al
Cabinet Bede S.A., Boulevard Général Wahis 15
1030 Bruxelles / BE
Application number, filing date04761472.204.08.2004
[2006/23]
WO2004BE00111
Priority number, dateWO2003BE0013205.08.2003         Original published format: PCT/BE0300/132
[2006/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005011642
Date:10.02.2005
Language:EN
[2005/06]
Type: A1 Application with search report 
No.:EP1663174
Date:07.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2005 takes the place of the publication of the European patent application.
[2006/23]
Search report(s)International search report - published on:EP10.02.2005
ClassificationIPC:A61K9/52, A61K9/36
[2006/23]
CPC:
A61K31/4415 (EP); A61K31/216 (EP); A61K31/525 (EP);
A61K31/714 (EP); A61K9/4808 (EP); A61K9/5084 (EP);
A61K9/1623 (EP); A61K9/2018 (EP); A61K9/2022 (EP);
A61K9/2027 (EP); A61K9/2826 (EP); A61K9/284 (EP);
A61K9/2866 (EP); A61K9/4858 (EP); A61K9/4866 (EP);
A61K9/5047 (EP) (-)
C-Set:
A61K31/216, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP);
A61K31/525, A61K2300/00 (EP);
A61K31/714, A61K2300/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/23]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:EINZELNE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM GEMISCH AUS EINEM FIBRAT UND EINEM HOMOCYSTEINE-REDUKTIONSMITTEL[2006/23]
English:SINGLE UNIT PHARMACEUTICAL COMPOSITION COMPRISING A MIXTURE OF A FIBRATE AND A HOMOCYSTEINE REDUCING AGENT[2006/23]
French:COMPOSITION PHARMACEUTIQUE A UNITE SIMPLE COMPRENANT UN MELANGE DE FIBRANNE ET UN AGENT REDUCTEUR D'HOMOCYSTEINE[2006/23]
Entry into regional phase24.02.2006National basic fee paid 
24.02.2006Designation fee(s) paid 
24.02.2006Examination fee paid 
Examination procedure04.03.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.02.2006Examination requested  [2006/23]
07.08.2006Despatch of a communication from the examining division (Time limit: M04)
07.12.2006Reply to a communication from the examining division
31.08.2007Despatch of a communication from the examining division (Time limit: M04)
11.01.2008Application deemed to be withdrawn, date of legal effect  [2008/30]
09.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/30]
Fees paidRenewal fee
24.02.2006Renewal fee patent year 03
30.08.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO0156609  (DIERKES JUTTA ; LULEY KLAUS (DE); WESTPHAL SABINE (DE)) [X] 1-4,8-12,15-17,19 * page 1, line 13 - page 2, line 13 * * page 8, line 5 - line 15 * [Y] 5,6,18 [I] 7,12-14,18,20,21;
 [XI]DE19910682  (DIERKES JUTTA ; LULEY CLAUS (DE); WESTPHAL SABINE (DE)) [X] 1-4,9,11,15-17 * column 1, line 50 - column 2, line 32 * * claims 1,2 * [I] 7,12-14,19-21;
 [Y]WO03013501  (SERENO ANTONIO ; SMB SA LAB (BE); BAUDIER PHILIPPE (BE); VANDERBIST FR) [Y] 5,18 * page 5, line 13 - line 26 * * example - *;
 [A]US6465013  (DEBERNARDI DOUGLAS P) [A] * column 2, line 65 - column 3, line 8 * * example - *
 [IY]  - DIERKES JUTTA ET AL, "Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate", ATHEROSCLEROSIS, (200109), vol. 158, no. 1, ISSN 0021-9150, pages 161 - 164, XP002288439 [I] 1-4,6-21 * abstract * * page 162, column L, line 6 - line 10 * * page 163, paragraph 1 * [Y] 6

DOI:   http://dx.doi.org/10.1016/S0021-9150(00)00766-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.